metaPreg - Acebutolol (versus unexposed) during pregnancy

Acebutolol (versus unexposed) updated on 12-17-2024

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	3.55 [1.27, 9.86]	-	1 study	4,058	49	not evaluable	ROB	6.55 [1.87; .]
Major congenital malformations	3.55 [1.27, 9.86]	-	1 study	4,058	49	not evaluable	ROB	6.55 [1.87; .]
Neonatal disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Fetal distress	30.33 [1.39, 660.79]	-	1 study	6	11	not evaluable	ROB	60.16 [2.13; .]
Neonatal bradycardia	21.00 [0.97, 453.94]	-	1 study	5	11	not evaluable	ROB	-
Neonatal hypoglycemia	5.71 [0.52, 62.66]	-	1 study	5	11	not evaluable	ROB	-
Neonatal hypotension	9.80 [0.44, 219.26]	-	1 study	3	11	not evaluable	ROB	-
Neonatal tachypnea	9.80 [0.44, 219.26]	-	1 study	3	11	not evaluable	ROB	-
Hide endpoints reported in only one study ...